Pomdoctor Ltd(POM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 12 at 8:35 AM ET (Korea 11/12 22:35)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | 6.3M | Perf Week | 7.1% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -33.19% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | - | Inst Own | 0.03% | Short Float | - | Perf Quarter | -51.18% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.13 | Perf Half Y | -78.4% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.25M | Perf YTD | -90.62% |
| Book/sh | -1.47 | P/C | 51.28 | EPS past 3/5Y | -47.9% -10.17% | ROE | - | 52W High | -99.51% ($341.39) | Perf Year | -99.48% |
| Cash/sh | 0.03 | P/FCF | - | Sales past 3/5Y | 15.17% 22.15% | ROIC | - | 52W Low | 140.58% ($0.69) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 17.66% 50.39% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.53 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.32 | EPS Q/Q | - | Profit Margin | - | RSI (14) | 46.12 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.35 | Sales Q/Q | - | SMA20 | -6.23% ($1.77) | Beta | 2.99 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | 2026/5/14 | SMA50 | -29.55% ($2.36) | Rel Volume | 0.03 | Prev Close | $1.6 |
| Employees | 165 | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | -81.46% ($8.95) | Avg Volume(3M) | 2.00M | Price | $1.66 |
| IPO | 2025/10/8 | Option/Short | No/Yes | Trades | 435 | Volume | 61,586 | Change | 3.75% |
🏥 It's a Chinese online healthcare platform specializing in chronic disease management. It operates two businesses: internet hospitals (teleconsultations and e-prescriptions) and a pharmaceutical supply chain (retail and wholesale pharmacy). It connects patients, doctors, and medications in a one-stop service. Headquartered in Guangzhou, the company listed on Nasdaq as an ADR in 2025.
Over the past 1 year, on the lower side
100% below its 1-year high.
Traded less than usual. That is 3% of its average volume.
Holding long would have lost money
Tap to view numbers
No dividend
There is no profit to distribute yet.
Institutions barely hold it
Institutions hold 0.0%.
Tap to view numbers
It ranks #3 of 5 in the industry
Based on market cap of $14M.
FAQ
What kind of company is POM?
POM belongs to the Healthcare sector and operates in the Pharmaceutical Retailers industry.
What is the market cap of POM?
The market cap of POM is approximately $14M, ranking 5,311 within its sector.
What is the 52-week high and low for POM?
POM has recorded a 52-week high of $341.39 and a low of $0.69.
